Updated: Mar 31, 2024
Based on 2 analysts giving stock ratings to Inhibikase Therapeutics in the past 3 months
Buy
Buy
Hold
Sell
Updated: Mar 31, 2024
The average Inhibikase Therapeutics stock price target is 17.50 with a max estimate of 27.00 and a min estimate of 8.00
Review Inhibikase Therapeutics earnings estimates
Receive timely notifications of rating changes
View more detailed ratings of institutions and analysts
View rating details page for historical data
Analyst Ratings Disclaimer
Updated: Mar 31, 2024
Buy
Buy
Hold
Sell
Updated: Mar 31, 2024